Haplo-identical Viral-Specific T-cells for Treatment of Cytomegalovirus and Adenovirus Infections After Hematopoietic Cell Transplantation

Abroad (travel likely)RecruitingPHASE2

Conditions

Cytomegalovirus · Adenovirus

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

St . Jude Children's Research Hospital, Memphis, Tennessee, United States
Contact: Study coordinator (Naik Swati, MD) · referralinfo@stjude.org · 866-278-5833
Contact: Principal Investigator (Naik Swati, MD)

Study leads

Naik Swati, MD
Principal Investigator
St. Jude Children's Research Hospital

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Viral Specific T-Lymphocytes to Treat Infection With Adenovirus, Cytomegalovirus or Epstein-Barr Virus in Patients With Compromised Immunity

Adenovirus · Cytomegalovirus Infections · Epstein-Barr Virus Infections

Abroad (travel likely)RecruitingPHASE1, PHASE2

Palo Alto, United States · Palo Alto, United States

A Phase 2a Study of IV BCV in Subjects With Adenovirus Infection

Adenovirus Infections · Cytomegalovirus Infection

Abroad (travel likely)RecruitingPHASE2

Los Angeles, United States · Los Angeles, United States

Donor Virus-Specific CMV or AdV CTL to Treat CMV or AdV Reactivation or Disease After Solid Organ or HCT

Allogeneic Hematopoietic Stem Cell Transplantation Recipient · Cytomegalovirus · Donor

Abroad (travel likely)RecruitingEARLY_PHASE1

Columbus, United States · Columbus, United States

Risk Assessment of Community Spread of Multiple Endemic Infectious Diseases in a One Health Perspective

Dengue · Chikungunya · Zika Virus Infection

Abroad (travel likely)Recruiting

Phnom Penh, Cambodia